Menu UF Health Home Menu

News Category Subscribe to RSS Feed


UF researchers publish paper on myxoma virus and T lymphocytes

Published: Aug 26th, 2015

The publication found that myxoma virus binds human T lymphocytes but does not enter and infect T cells until after activation.


UF type 1 researcher Dr. Martha Campbell-Thompson and collaborators identify novel diabetes-linked proteins

Published: Aug 25th, 2015

Dr. Campbell-Thompson and her collaborators recently published a paper titled ‘Proteomic Analysis of Disease Stratified Human Pancreas Tissue Indicates Unique Signature of Type 1 Diabetes.’ From the publication: “the study […]


New resource for diabetes investigators: the Helmsley Cellular Research Hub

Published: Aug 25th, 2015

UFDI helped establish this new collaborative cell hub, a source for qualified scientists to access somatic and pluripotent cell lines obtained from well-phenotyped type 1 diabetes patients.


UF type 1 researcher’s article selected as editor’s choice in Science Translational Medicine

Published: Aug 24th, 2015

Dr. Cherie Stabler’s work on using biomaterials to mimic regulatory T cells was featured in the latest volume of Science Translational Medicine.


Organ donor specimens: What can they tell us about type 1 diabetes?

Published: Aug 18th, 2015

UFDI researcher Dr. Martha Campbell-Thompson recently published an article on the Network for Pancreatic Organ Donors with Diabetes’s pancreatic tissue collection. Dr. Campbell highlights key findings from the nPOD collection.

grip strength

Grip strength may help identify people with undiagnosed diabetes

Published: Jul 29th, 2015

Muscle strength may play a role in cardiometabolic disease. A new study led by Arch Mainous III, Ph.D., College of Public Health and Health Professions, finds that that grip strength measurements may be an effective way to identify cases of undiagnosed diabetes and high blood pressure. Read more.


ITN opens EXTEND Study in Type 1 Diabetes | Immune Tolerance Network

Published: Jul 15th, 2015

The University of Florida is among the first sites nationwide to offer The EXTEND trial, a new clinical trial that will test the ability of the drug tocilizumab to slow disease progression and may help maintain natural insulin production in individuals with newly diagnosed Type 1 diabetes. For more information, contact the University of Florida Type 1 Diabetes TrialNet research team; 352-294-5761.

Schatz 2015 Medium

Associated Press | Researchers study insulin pills to prevent diabetes

Published: Jul 15th, 2015

Dr. Desmond Schatz, medical director of the UF Diabetes Institute, was quoted in a recent story on new research being done that could prevent Type 1 diabetes. “We know so very little about the exact mechanisms that cause Type 1 diabetes, which complicates efforts to prevent it.” Read more.


UF professor receives AADE award for diabetes research

Published: Jul 7th, 2015

Assistant Professor Anastasia Albanese-O’Neill received the 2015 Innovative Use of Media Technology Award from the American Association of Diabetes Educators. As the recipient of this award she will receive $3,000.00 for the development and/ or implementation of a concept for the innovative use of media and technology to advance diabetes self-management education and training.

Stabler Image 2

Dr. Stabler awarded $1M microencapsulation grant from JDRF

Published: Jun 11th, 2015

Dr. Cherie Stabler, along with her collaborator Dr. Andrés Garcia (Georgia Institute of Technology), were awarded a 3-year grant from JDRF on their collaborative project entitled “Engineered Bioactive Hydrogel Macrodevices for Islet Transplantation”. The aim of Dr. Stabler’s research is to create a long-term cell-based implant for treatment of Type 1 diabetes. Read more.